Researchers Find 2 Melanoma Protein Clues to Predict Immunotherapy Benefit
Updated
Updated · Oncodaily · Aug 2
Researchers Find 2 Melanoma Protein Clues to Predict Immunotherapy Benefit
2 articles · Updated · Oncodaily · Aug 2
Summary
Protein markers identified in melanoma may help predict which patients will benefit from immunotherapy, according to research highlighted by Iylon Precision Oncology.
Researchers reached that finding by tracking how melanoma cells and immune cells interact and how proteins change during an immune attack.
The same analysis also pointed to melanoma weak spots that could be targeted with new treatments, extending the work beyond patient selection.
Those results could support precision oncology by improving biomarker discovery and guiding more personalized immunotherapy for melanoma patients.